𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

✍ Scribed by G. F. Handeland; U. Abildgaard; H. A. Holm; K. E. Arnesen


Publisher
Springer
Year
1990
Tongue
English
Weight
645 KB
Volume
39
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Heparin/dihydroergotamine for venous thr
✍ Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. MΓΈller-Larsen; V. E. Knud πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 495 KB πŸ‘ 2 views

Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo

Home treatment of deep venous thrombosis
✍ Enric Grau; Jose M. Tenias; Esperanza Real; Jose Medrano; Rosario Ferrer; Emilio πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 2 views

## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3–6 mon